PARTNERING

Actuate Therapeutics is open to partnering with academic and life science companies to license, acquire, or partner on the development of novel compounds for oncology and inflammatory fibrotic diseases.

For partnering discussions, please contact:

Daniel M. Schmitt
President and CEO
dschmitt@actuatetherapeutics.com